In the Oscar-season finale of The Envelope video podcast, we sit down with Colman Domingo, lead actor nominee for 'Sing Sing.
Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours overexpress c-Met. The c-Met protein ...